These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19112724)

  • 21. [Chronic end-stage kidney failure in Mexico].
    Hernández-Llamas G; Espinoza-Vázquez B; Exaire-Murad E; Bordes-Aznar J; Dib-Kuri A; Tamayo y Orozco JA
    Gac Med Mex; 1995; 131(4):459-63. PubMed ID: 8948907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focus on: physical exercise in hemodialysis patients.
    Tentori F
    J Nephrol; 2008; 21(6):808-12. PubMed ID: 19034864
    [No Abstract]   [Full Text] [Related]  

  • 23. [What should nephrologists know about cardiac illnesses in patients on peritoneal dialysis?].
    Alonso Gómez AM
    Nefrologia; 2008; 28 Suppl 6():105-12. PubMed ID: 18957020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipid profiles in peritoneal dialysis].
    Pagniez D
    Nephrologie; 2000; 21(7):361-2. PubMed ID: 11200612
    [No Abstract]   [Full Text] [Related]  

  • 26. [Arterio-venous fistula and cardiovascular system disturbances].
    Głowińska I; Głowinski J; Gacko M; Małyszko J
    Przegl Lek; 2008; 65(12):858-61. PubMed ID: 19441678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk profile assessment and medication control should come first.
    Zoccali C; Mallamaci F; Tripepi G
    Semin Dial; 2007; 20(5):405-8. PubMed ID: 17897245
    [No Abstract]   [Full Text] [Related]  

  • 28. Statin use prolongs patient survival after renal transplantation.
    Ritz E; Wanner C
    J Am Soc Nephrol; 2008 Nov; 19(11):2037-40. PubMed ID: 18842988
    [No Abstract]   [Full Text] [Related]  

  • 29. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hyperhomocysteinemia as a risk factor for cardiovascular diseases in patients with chronic renal failure].
    Małecki R
    Pol Arch Med Wewn; 2000 Oct; 104(4):695-701. PubMed ID: 11392158
    [No Abstract]   [Full Text] [Related]  

  • 31. [Atrial fibrillation and dialysis. A convergence of risk factors].
    Grande A
    Rev Esp Cardiol; 2006 Aug; 59(8):766-9. PubMed ID: 16938224
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of chronic kidney disease in primary health care: position paper of the European Forum for Primary Care.
    Rosenberg M; Kalda R; Kasiulevicius V; Lember M;
    Qual Prim Care; 2008; 16(4):279-94. PubMed ID: 18718165
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular disease in patients with chronic renal failure.
    Wheeler DC
    Lancet; 1996 Dec 21-28; 348(9043):1673-4. PubMed ID: 8973424
    [No Abstract]   [Full Text] [Related]  

  • 34. Dialysis: Advances in Chronic Kidney Disease. Preface.
    Ronco C; Levin NW
    Blood Purif; 2008; 26(1):5. PubMed ID: 18182787
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic renal failure management-Part I.
    Nickas GM
    Ariz Med; 1980 Sep; 37(9):637-8. PubMed ID: 7436771
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cardiovascular disease in chronic kidney failure].
    Os I
    Tidsskr Nor Laegeforen; 2008 May; 128(11):1297. PubMed ID: 18546586
    [No Abstract]   [Full Text] [Related]  

  • 37. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mortality in renal failure and therapeutic programs at the 1st Tokyo National Hospital].
    Ueno A; Hirokawa I; Nakano I
    Iryo; 1970 Jun; 24(6):488-90. PubMed ID: 5456510
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
    Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments in cardiovascular risk assessment: relevance to the nephrologist.
    Koenig W
    Nephrol Dial Transplant; 2011 Oct; 26(10):3080-3. PubMed ID: 21633098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.